Skip to search formSkip to main contentSkip to account menu

spicamycin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Excellence in neuropathic pain management continues to challenge the ability of health care providers. Current medications are… 
2003
2003
Neuropathic pain is a significant clinical problem. Currently, there are no drugs that produce complete amelioration of this type… 
1997
1997
The spicamycin analogue KRN5500 (NSC 650426; SPA) is derived from Streptomyces alanosinicus. The unique structure contains a… 
1995
1995
New derivatives of spicamycin modified at the fatty acid moieties of the molecule were synthesized and their structure-activity… 
1995
1995
Spicamycin (SPM), produced by Streptomyces alanosinicus, induces potent differentiation in a human leukemia cell line, HL60. One… 
1995
1995
a Pharmaceutical Research Laboratory, Kirin Brewery Co., Ltd., 3, Miyahara-cho, Takasaki-shi, Gunma 370-12, Japan bThe Institute… 
1994
1994
KRN5500, (6-[4-Deoxy-4-(2E,4E)-tetradecadienoylglycyl]amino-L-glycero - beta-L-mannoheptopyranosyl]amino-9H-purine), was semi… 
1994
1994
The antitumor activity of spicamycin analogue SPM VIII against human stomach, breast, lung, colon and esophageal cancers was… 
1983
1983
cells,1,2) we have recently isolated an active substance from the culture broth of a streptomycete. This antibiotic "spicamycin…